Interestingly, the potential of reversing PV recruitment and dysfunction in another 22q11DS mouse model was recently shown by an antipsychotic treatment (D2 dopamine receptor antagonists) although the rescue was only seen when administered during late adolescence61. Here, DRD2 is linked to 22q11.2 deletion syndrome.